Business Description
Athira Pharma Inc
NAICS : 541714
SIC : 2833
Description
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 106.1 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -44.2 | |||||
| 3-Year EPS without NRI Growth Rate | -45.6 | |||||
| 3-Year FCF Growth Rate | -48.2 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.67 | |||||
| 9-Day RSI | 33.06 | |||||
| 14-Day RSI | 32.74 | |||||
| 12-1 Month Momentum % | -24.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.87 | |||||
| Quick Ratio | 8.87 | |||||
| Cash Ratio | 8.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -82.9 | |||||
| Shareholder Yield % | 0.07 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -45.88 | |||||
| ROA % | -42.58 | |||||
| ROIC % | -258.63 | |||||
| ROC (Joel Greenblatt) % | -1899.37 | |||||
| ROCE % | -44.05 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.41 | |||||
| Price-to-Tangible-Book | 0.41 | |||||
| EV-to-EBIT | 1.05 | |||||
| EV-to-EBITDA | 1.06 | |||||
| EV-to-FCF | 1.23 | |||||
| Price-to-Net-Current-Asset-Value | 0.45 | |||||
| Price-to-Net-Cash | 0.46 | |||||
| Earnings Yield (Greenblatt) % | 95.24 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ATHA
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Athira Pharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.83 | ||
| Beta | 2.81 | ||
| Volatility % | 53.93 | ||
| 14-Day RSI | 32.74 | ||
| 14-Day ATR ($) | 0.111403 | ||
| 20-Day SMA ($) | 2.1285 | ||
| 12-1 Month Momentum % | -24.09 | ||
| 52-Week Range ($) | 1.94 - 4.41 | ||
| Shares Outstanding (Mil) | 38.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Athira Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Athira Pharma Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Athira Pharma Inc Frequently Asked Questions
What is Athira Pharma Inc(ATHA)'s stock price today?
The current price of ATHA is $1.98. The 52 week high of ATHA is $4.41 and 52 week low is $1.94.
When is next earnings date of Athira Pharma Inc(ATHA)?
The next earnings date of Athira Pharma Inc(ATHA) is 2023-11-10 Est..
Does Athira Pharma Inc(ATHA) pay dividends? If so, how much?
Athira Pharma Inc(ATHA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers